VSTM - Verastem Inc

Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in Needham, Massachusetts.

52W High

$11.25

52W Low

$2.40

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.93

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.19

EV/Revenue (<3 favorable)

272.92

P/S (TTM) (<3 favorable)

310.17

P/B (<3 favorable)

18.38

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.82%

Institutions (25–75% balanced)

89.05%

Shares Outstanding

61,545,000

Float

45,882,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,137,000

Gross Profit (TTM)

1,819,000

EPS (TTM)

-3.50

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-20.48%

ROE (TTM) (>15% strong)

-4.38%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.79

Momentum

Bearish momentum

Value

1.1799

1.0972

Trend

Rising

Signal Cross

No cross

As of

Sep. 05, 2025